Login / Signup

Socioeconomic burden of AQP4-antibody seropositive NMOSD: a nationwide registry-based study.

Viktoria PappMalthe Wandall-HolmKristina Bacher SvendsenJette FrederiksenFinn SellebjergZsolt IllesMelinda Magyari
Published in: Journal of neurology, neurosurgery, and psychiatry (2024)
The socioeconomic status of patients with AQP4-Ab+NMOSD deteriorates rapidly following disease onset. A substantial proportion of these patients lose their work capacity leading to increased financial burden on both their families and society.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors
  • healthcare
  • risk factors
  • cross sectional
  • health insurance
  • childhood cancer